 |
 |

Xerostomia Prevention After Head and Neck Cancer Treatment
Arch Otolaryngol Head Neck Surg. 2003;129:250-251.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Xerostomia is a serious problem that impacts patients' quality of life negatively. Salivary gland dysfunction impairs mastication, deglutition, and gustation while heightening the susceptibility of the oral hard and soft tissues to a variety of destructive processes. Drs Nagler and Baum have presented a good summary of the theories of salivary gland irradiation damage and a comprehensive review of the pharmacologic manipulation used in preserving salivary function during radiation. The concept of gene transfer is intriguing but it is unlikely to be of clinical use for many years. There are, however, numerous methods presently available to the clinician that effectively preserve salivary function and, in some patients, prevent posttreatment xerostomia. These methods can be broadly classified into 3 categories: chemoprevention, parotid gland sparing, and submandibular and sublingual gland sparing.
Figure appears in full text version.
|
|
|
|
|
CHEMOPREVENTION
This topic has been well covered by Drs Nagler and Baum. The 2 agents most commonly used in . . . [Full Text of this Article]
PAROTID GLAND SPARING
SUBMANDIBULAR AND SUBLINGUAL GLAND SPARING
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Prophylactic Treatment Reduces the Severity of Xerostomia Following Radiation Therapy for Oral Cavity Cancer
Rafael M. Nagler and Bruce J. Baum
Arch Otolaryngol Head Neck Surg. 2003;129(2):247-250.
EXTRACT
| FULL TEXT
Clinical Commentary on Prophylactic Treatment of Radiation-Induced Xerostomia
Mark S. Chambers
Arch Otolaryngol Head Neck Surg. 2003;129(2):251-252.
EXTRACT
| FULL TEXT
|